Poly Pharm

Hainan Poly Pharm. Co., Ltd. was established in 1992 and is a high-tech enterprise specializing in drug research and development, registration, production, and sales. Adhering to the corporate mission of "Benefiting the world with universal care, and bringing health benefits," the company is committed to providing products and services with therapeutic value to patients and customers worldwide. Through the construction of three high-end pharmaceutical preparation and API manufacturing bases in Haikou, Hangzhou, and Anqing, the company's preparation dosage forms cover injections, tablets, capsules, dry suspensions (granules), eye drops, and ointments. The chemical reactions involved in APIs include hydrogenation, reduction, oxidation, halogenation, chlorination, bromination, iodination, alkylation, and Grignard reactions, while common processes include acylation, substitution, thiolation, condensation, rearrangement, and chelation. This achieves the integration of the entire drug manufacturing industry chain, forming integration of key intermediates, APIs, and preparations. The company has now become one of China's top 100 listed companies in scientific and technological innovation, a pioneer in the internationalization of Chinese pharmaceutical preparations, and a national intelligent manufacturing enterprise designated by the Ministry of Industry and Information Technology. It has been included in the 2016 Industrial Transformation and Upgrading - Made in China 2025 key project for children's drugs by the Ministry of Industry and Information Technology.